Rupali Roy Bhave, MD
- Clinical Assistant Professor, Hematology and Oncology Hematology and Oncology

- Education
- MD, University of Arizona College of Medicine, 2006
- Residency
- Department of Medicine, University of Virginia Medical Center, 2009
- Board Certifications
- American Board of Internal Medicine, Hematology
- American Board of Internal Medicine, Medical Oncology
- Positions
- Clinical Assistant Professor, Hematology and Oncology
- Assistant Professor, Hematology and Oncology
- Departments and Affiliations
- Hematology and Oncology
- Comprehensive Cancer Center
Research
- Prostaglandin E1 and Its Analog Misoprostol Inhibit Human CML Stem Cell Self-Renewal via EP4 Receptor Activation and Repression of AP-1. Li F, He B, Ma X, Yu S, Bhave RR, Lentz SR, Tan K, Guzman ML, Zhao C, Xue HH. Cell Stem Cell. 2017 09; 21(3):359-373.e5.
- Study Comparing the Addition of the Drug Crenolanib to Chemotherapy to Chemotherapy Alone in Patients with Acute Myeloid Leukemia
- Testing the Addition of Pembrolizumab to the Usual Treatment for Newly Diagnosed Acute Myeloid Leukemia
- Study Comparing Two Different Treatments Using Tamibarotene (study drug) for Newly Diagnosed Adult Patients Selected for RARA-positive Higher-Risk Myelodysplastic Syndrome